799-2173227-8/11/1

AbbVie Deutschland GmbH & Co. KG — FEI 3002807401

Refusal Details

Date
August 13, 2024
Country
Germany
Product Category
Drugs and Biologics
Product Code
58SCK14 ADALIMUMAB
Charges
75